A Little Alcohol May Stave Off Alzheimer's
WEDNESDAY, March 9 (HealthDay News) -- Drinking light to
moderate amounts of alcohol may actually lower the risk for
developing both Alzheimer's and some forms of age-related dementia,
new German research suggests.
Follow-Up Deemed Lacking for People Taking Opioids
WEDNESDAY, March 9 (HealthDay News) -- Though opioid
painkillers, such as oxycodone, can lead to addiction and overdose,
people who take them are frequently not tracked by the primary care
doctors who prescribed the drugs, a new study has found.
Classroom Environment May Affect Kids' Mental Health
WEDNESDAY, March 9 (HealthDay News) -- First-grade classrooms
with poor environments -- not enough resources, teachers who feel
disrespected by colleagues -- have been linked to a higher number
of mental health problems in students, according to a new
study.
Lost DNA May Have Made Us More Human
WEDNESDAY, March 9 (HealthDay News) -- What difference does it
make if
homo sapiens lost a snippet of DNA over the millennia? A lot,
as it turns out.
Risk-Glorifying Media Linked to Reckless Behavior
WEDNESDAY, March 9 (HealthDay News) -- People exposed to video
games, television, movies, music and advertising that glorify risky
behavior are more likely to take real-life risks, new research
suggests.
Home Genetic Tests May Need Doctor's Involvement: FDA
WEDNESDAY, March 9 (HealthDay News) -- Some genetic tests sold
directly to consumers that might help to predict health risks may
need to be supplied through doctors, a U.S. Food and Drug
Administration official said Wednesday,
Bloomberg News reported.
Lesser Known Lung Diseases Can Strike Smokers, Ex-Smokers
WEDNESDAY, March 9 (HealthDay News) -- A sizable minority of
smokers and former-smokers develop lung conditions that reduce lung
capacity, but leave them less likely to have either emphysema or
chronic obstructive pulmonary disease (COPD), new research
shows.
FDA Approves 1st New Lupus Drug in More Than 5 Decades
WEDNESDAY, March 9 (HealthDay News) -- The U.S. Food and Drug
Administration on Wednesday gave lupus patients their first new
treatment option in more than 50 years when it approved Benlysta as
a way to ease the painful symptoms of this debilitating autoimmune
disorder.